Active substances
Calcium chloride + Magnesium chloride + Sodium acetate + Sodium chloride
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| HAEMODIALYSIS CONC.SOLU.35X FORM.(12) | 214.77,9,5.34,166.72 g/l,g/l,g/l,g/l | Concentrate for solution for haemodialysis · Parenteral use | 1 Bag | SAR 45.55 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| HAEMODIALYSIS CONC.SOLU.35X FORM.(19) | 200.45,9,5.34,190.54 g/l,g/l,g/l,g/l | Concentrate for solution for haemodialysis · Parenteral use | 1 Bag | SAR 45.55 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| NON PYROGENIC ACETATE F6(3-006-010) I.V | Solution · Intravenous use | 1 Ampoule | SAR 41.00 | NCE · Prescription | ARABIAN DIAGNOSTIC AND MEDICAL COMPANY | Invalid · Not Marketed |
Indications — CHI Daman Drug Formulary
DIALYSIS
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.